The U.S. Food and Drug Administration has approved Yuvezzi (carbachol and brimonidine tartrate) ophthalmic solution 2.75%/0.1%, previously known as Brimochol PF, as the first and only dual-agent eye drop for the treatment of presbyopia in adults.
Source: https://medicalxpress.com/news/2026-02- ... yopia.html
-
Translation